Endocrine Products
These compounds are studied in preclinical endocrine research models examining receptor signaling pathways. For laboratory research use only.
Research Use Only - Not for human or animal consumption.
CJC-1295 without drug affinity complex (DAC) is a synthetic 30-amino-acid analog of growth hormone releasing hormone. Studied in preclinical endocrine research for its activity at the GHRH receptor. Lyophilized.
Available research sizes: 5mg, 10mg
CJC-1295 with drug affinity complex (DAC) is a modified GHRH analog with extended half-life through albumin binding. Studied in preclinical endocrine research. Lyophilized.
Available research sizes: 5mg
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). Studied in preclinical endocrine research for its selective activity at the GHS-R1a (ghrelin) receptor. Lyophilized.
Available research sizes: 5mg, 10mg
Tesamorelin is a synthetic analog of growth hormone releasing hormone with a hexenoyl group modification at the N-terminus for enhanced stability. Studied in preclinical endocrine research for its activity at the GHRH receptor. Lyophilized.
Available research sizes: 2mg, 5mg, 10mg
GHRP-2 is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2). Studied in preclinical endocrine research for its activity at the GHS-R1a (ghrelin) receptor. Lyophilized.
Available research sizes: 10mg
GHRP-6 is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2). Studied in preclinical endocrine research for ghrelin receptor pathway activity. Lyophilized.
Available research sizes: 10mg
Sermorelin is the synthetic 29-amino-acid N-terminal fragment of human growth hormone releasing hormone. Studied in preclinical endocrine research for GHRH receptor activity. Lyophilized.
Available research sizes: 5mg, 10mg
Recombinant 191-amino-acid human growth hormone (somatropin). Studied extensively in preclinical endocrine, metabolic, and tissue research. Supplied as a lyophilized powder.
Available research sizes: 10iu, 15iu, 24iu
Synthetic fragment of the human growth hormone C-terminus (residues 176–191). Studied in preclinical research for lipolytic pathway activity independent of IGF-1 signaling. Lyophilized.
Available research sizes: 1mg, 2mg, 5mg
IGF-1 LR3 is a modified analog of insulin-like growth factor 1 with an extended N-terminal arginine substitution. Studied in preclinical research for its activity at the IGF-1 receptor with reduced binding to IGFBPs. Lyophilized.
Available research sizes: 100mcg, 1mg
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analog of α-MSH. Studied in preclinical research for its activity at the melanocortin-4 receptor (MC4R). Lyophilized.
Available research sizes: 10mg
Human chorionic gonadotropin is a 237-amino-acid glycoprotein hormone. Studied in preclinical endocrine research for its activity at the LH/hCG receptor. Lyophilized.
Available research sizes: 5000iu, 10000iu
Human menopausal gonadotropin contains both follicle stimulating hormone (FSH) and luteinizing hormone (LH) activity. Studied in preclinical endocrine and reproductive pathway research. Lyophilized.
Available research sizes: 75iu
A research blend combining CJC-1295 (No DAC) and Ipamorelin (5mg each). Studied in preclinical research for combined GHRH receptor and GHS-R1a receptor pathway activity. Lyophilized.
Available research sizes: 10mg
Gonadorelin acetate is the synthetic acetate salt of gonadotropin releasing hormone, a 10-amino-acid hypothalamic peptide. Studied in preclinical endocrine research for GnRH receptor activity. Lyophilized.
Available research sizes: 2mg, 5mg